Cooper Health Systems is a clinical research site located in Camden, New Jersey, United States 08103.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Cooper Health Systems has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis, Peripheral Arteriosclerosis.
Sponsors: Cordis US Corp., Edwards Lifesciences, BioMarin Pharmaceutical.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cooper Health Systems has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cooper Health Systems has 4 clinical trials on record, with 1 currently active. Their work covers Angioplasty, Transluminal, Percutaneous Coronary, Coronary Arteriosclerosis, Peripheral Arteriosclerosis.
Yes — Cooper Health Systems holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.